New liposidomycin congeners produced by Streptomyces sp. TMPU-20A065, anti- Mycobacterium avium complex agents with therapeutic efficacy in a silkworm infection model

Akiho Yagi,Mayu Fujiwara,Mayu Sato,Yuzu Abe,Ryuji Uchida
DOI: https://doi.org/10.1038/s41429-024-00724-4
2024-05-08
The Journal of Antibiotics
Abstract:Three new liposidomycin congeners ( 1 , 2 , and 4 ), together with 14 known liposidomycins ( 3 and 5 – 17 ), were isolated from the culture broth of Streptomyces sp. TMPU-20A065 as anti- Mycobacterium avium complex agents. The structures of liposidomycins were elucidated by spectroscopic analyses, including NMR and MS. Compounds 1 , 2 , and 4 belong to type-I liposidomycin-containing sulfate groups and methylglutaric acid, each with a different acyl side chain in the structure. Compounds 1 – 17 exhibited in vitro anti- M. avium and M. intracellulare activities with MIC values ranging between 2.0 and 64 μg ml −1 . Furthermore, 1 – 17 exerted potent therapeutic effects in an in vivo-mimic silkworm infection model with ED 50 values ranging between 0.12 and 3.7 μg larva −1 g −1 .
pharmacology & pharmacy,immunology,biotechnology & applied microbiology,microbiology
What problem does this paper attempt to address?